A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer

Journal of Hepatology

Volumn 52, Issue 2, 2010, Pages 228-233

  Wen, He ^a   Yoo, Sung Soo ^a   Kang, Jinho ^a   Kim, Hee Goo ^a   Park, Jin Seok ^a   Jeong, Seok ^a   Lee, Jung Il ^a   Kwon, Hyuk Nam ^a   Kang, Sunmi ^a   Lee, Don Haeng ^a   Park, Sunghyouk ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Bile; Biliary tract cancer; Diagnosis; Metabolomics

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; BILIARY TRACT DISEASE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CYTOLOGY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; ENDOSCOPY; FEMALE; HUMAN; LEAVE ONE OUT ANALYSIS; MALE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PARTIAL LEAST SQUARES REGRESSION; PATTERN RECOGNITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TOTAL CORRELATION SPECTROSCOPY;

ADULT; AGED; AGED, 80 AND OVER; BILE; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES;

EID: 75549086735     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.11.002     Document Type: Article

References (38)

1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 (2001) 1353-1357
2. El Rassi Z.E., Partensky C., Scoazec J.Y., Henry L., Lombard-Bohas C., and Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25 (1999) 375-380
3. Taylor-Robinson S.D., Toledano M.B., Arora S., Keegan T.J., Hargreaves S., Beck A., et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48 (2001) 816-820
4. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2 (2002) 10
5. Ohtsuka M., Ito H., Kimura F., Shimizu H., Togawa A., Yoshidome H., et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89 (2002) 1525-1531
6. Ueno N., Sano T., Kanamaru T., Tanaka K., Nishihara T., Idei Y., et al. Adenosquamous cell carcinoma arising from the papilla major. Oncol Rep 9 (2002) 317-320
7. Saito M., Hige S., Takeda H., Tomaru U., Shibata M., and Asaka M. Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct. J Gastroenterol 36 (2001) 842-847
8. Matsumoto A., Imamura M., Akagi Y., Kaibara A., Ohkita A., Mizobe T., et al. A case report of disseminated recurrence of inferior bile duct carcinoma in PTCD fistula. Kurume Med J 49 (2002) 71-75
9. Siqueira E., Schoen R.E., Silverman W., Martin J., Rabinovitz M., Weissfeld J.L., et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 56 (2002) 40-47
10. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 85 (1990) 350-355
11. Perkins G.L., Slater E.D., Sanders G.K., and Prichard J.G. Serum tumor markers. Am Fam Physician 68 (2003) 1075-1082
12. Qin X.L., Wang Z.R., Shi J.S., Lu M., Wang L., and He Q.R. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol 10 (2004) 427-432
13. Carpelan-Holmstrom M., Louhimo J., Stenman U.H., Alfthan H., and Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22 (2002) 2311-2316
14. Bjornsson E., Kilander A., and Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 19 (1999) 501-508
15. Davidson B., Varsamidakis N., Dooley J., Deery A., Dick R., Kurzawinski T., et al. Value of exfoliative cytology for investigating bile duct strictures. Gut 33 (1992) 1408-1411
16. Osnes M., Serck-Hanssen A., and Myren J. Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol 10 (1975) 829-831
17. de Bellis M., Fogel E.L., Sherman S., Watkins J.L., Chappo J., Younger C., et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc 58 (2003) 176-182
18. Kurzawinski T., Deery A., and Davidson B.R. Diagnostic value of cytology for biliary stricture. Br J Surg 80 (1993) 414-421
19. Logrono R., Kurtycz D.F., Molina C.P., Trivedi V.A., Wong J.Y., and Block K.P. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Arch Pathol Lab Med 124 (2000) 387-392
20. Mahmoudi N., Enns R., Amar J., AlAli J., Lam E., and Telford J. Biliary brush cytology: factors associated with positive yields on biliary brush cytology. World J Gastroenterol 14 (2008) 569-573
21. Vandervoort J., Soetikno R.M., Montes H., Lichtenstein D.R., Van Dam J., Ruymann F.W., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 49 (1999) 322-327
22. Kim H.J., Kim M.H., Myung S.J., Lim B.C., Park E.T., Yoo K.S., et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 94 (1999) 1941-1946
23. 1H-NMR-based metabonomics. Nat Med 8 (2002) 1439-1444
24. Goodacre R., Vaidyanathan S., Dunn W.B., Harrigan G.G., and Kell D.B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 22 (2004) 245-252
25. Claudino W.M., Quattrone A., Biganzoli L., Pestrin M., Bertini I., and Di Leo A. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25 (2007) 2840-2846
26. Park S.Y., Park C.H., Cho S.B., Yoon K.W., Lee W.S., Kim H.S., et al. The safety and effectiveness of endoscopic biliary decompression by plastic stent placement in acute suppurative cholangitis compared with nasobiliary drainage. Gastrointest Endosc 68 (2008) 1076-1080
27. 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines. J Agric Food Chem 56 (2008) 11589-11595
28. Kang J., Lee S., Kang S., Kwon H.N., Park J.H., Kwon S.W., et al. NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins. Arch Pharm Res 31 (2008) 330-336
29. Kim K., Aronov P., Zakharkin S.O., Anderson D., Perroud B., Thompson I.M., et al. Urine metabolomic analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8 (2009) 558-570
30. Wiklund S., Johansson E., Sjostrom L., Mellerowicz E.J., Edlund U., Shockcor J.P., et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80 (2008) 115-122
31. 1H NMR data sets. Anal Chem 77 (2005) 1282-1289
32. Nakeeb A., Pitt H.A., Sohn T.A., Coleman J., Abrams R.A., Piantadosi S., et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473 discussion 473-465
33. Henson D.E., Albores-Saavedra J., and Corle D. Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer 70 (1992) 1493-1497
34. Henson D.E., Albores-Saavedra J., and Corle D. Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival rates. Cancer 70 (1992) 1498-1501
35. Farley D.R., Weaver A.L., and Nagorney D.M. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70 (1995) 425-429
36. de Groen P.C., Gores G.J., LaRusso N.F., Gunderson L.L., and Nagorney D.M. Biliary tract cancers. N Engl J Med 341 (1999) 1368-1378
37. Park S.W., Song S.Y., Chung J.B., Jung B.G., Moon Y.M., Kang J.K., et al. Combined endoscopic transpapillary biopsy and exfoliative cytology for the diagnosis of bile duct cancer. Korean J Gastrointest Endosc 19 (1999) 588-596
38. Wang J.N., Zhou Y., Zhu T.Y., Wang X., and Guo Y.L. Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. J Proteome Res 7 (2008) 3597-3601